For example, the promoter regions of genes such as PIK3CA and cyclin-dependent kinase inhibitor 2A (CDKN2A) show high levels of methylation in EBVaGC, which not only affects the expression of these genes but may also reduce metastatic potential by inhibiting tumor stemness. The gene discussed is CDKN2A; the disease is neoplasm.